In the second set of experiments, we observed that wtPV-H1 and rPVH1-yCD/5-FC treatment applied 2 days after implantation of tumor cells effectively delays the detection of the tumor marker CEA in the blood. This evidence concerns the gene CEACAM5 and neoplasm.